Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 20

1.

Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.

Cao J, Wan S, Tian J, Li S, Deng D, Qian Z, Gu Y.

Contrast Media Mol Imaging. 2012 Jul-Aug;7(4):390-402. doi: 10.1002/cmmi.1464.

PMID:
22649045
2.

Assessing intraoperative blood flow in cardiovascular surgery.

Yamamoto M, Sasaguri S, Sato T.

Surg Today. 2011 Nov;41(11):1467-74. doi: 10.1007/s00595-010-4553-0. Epub 2011 Oct 4. Review.

PMID:
21969147
3.

Indocyanine green angiography: a perspective on use in the clinical setting.

Yannuzzi LA.

Am J Ophthalmol. 2011 May;151(5):745-751.e1. doi: 10.1016/j.ajo.2011.01.043.

PMID:
21501704
4.

The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery.

Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL.

J Surg Oncol. 2011 Sep 1;104(3):323-32. doi: 10.1002/jso.21943. Epub 2011 Apr 14. Review.

5.

Positron emission tomography tracers for imaging angiogenesis.

Haubner R, Beer AJ, Wang H, Chen X.

Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S86-103. doi: 10.1007/s00259-010-1503-4. Review.

6.

Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective.

Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M.

J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):385-8. doi: 10.1007/s00534-009-0228-x. Epub 2009 Nov 20. Review.

PMID:
19936599
7.

Fluorescent peptide probes for in vivo diagnostic imaging.

Tung CH.

Biopolymers. 2004;76(5):391-403.

PMID:
15389488
8.

Lighting up tumors with receptor-specific optical molecular probes.

Achilefu S.

Technol Cancer Res Treat. 2004 Aug;3(4):393-409. Review.

PMID:
15270591
9.

Integrins: roles in cancer development and as treatment targets.

Jin H, Varner J.

Br J Cancer. 2004 Feb 9;90(3):561-5. Review.

10.

The diverse roles of integrins and their ligands in angiogenesis.

Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, Hodivala-Dilke K, Xiao Q.

Cold Spring Harb Symp Quant Biol. 2002;67:143-53. Review. No abstract available.

PMID:
12858535
11.

Alpha(v)beta(3) integrin in angiogenesis and restenosis.

Kerr JS, Mousa SA, Slee AM.

Drug News Perspect. 2001 Apr;14(3):143-50.

PMID:
12819820
12.

Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis.

Kumar CC.

Curr Drug Targets. 2003 Feb;4(2):123-31. Review.

PMID:
12558065
13.

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Ntziachristos V, Bremer C, Weissleder R.

Eur Radiol. 2003 Jan;13(1):195-208. Epub 2002 Jul 19. Review.

PMID:
12541130
14.

alphav Vitronectin receptors in vascular-mediated disorders.

Mousa SA.

Med Res Rev. 2003 Mar;23(2):190-9. Review.

PMID:
12500288
15.
16.
17.

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.

Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grötzinger C.

Nat Biotechnol. 2001 Apr;19(4):327-31.

PMID:
11283589
18.

Integrins and bone--cell adhesion and beyond.

Grzesik WJ.

Arch Immunol Ther Exp (Warsz). 1997;45(4):271-5. Review.

PMID:
9523000
19.

Integrins and cancer.

Varner JA, Cheresh DA.

Curr Opin Cell Biol. 1996 Oct;8(5):724-30. Review.

PMID:
8939661
20.

Tumor angiogenesis and the role of vascular cell integrin alphavbeta3.

Varner JA, Cheresh DA.

Important Adv Oncol. 1996:69-87. Review.

PMID:
8791129

Supplemental Content

Support Center